Overexpression of IMP2 or of its splice variant p62 (also known as IMP2-2 or IGF2BP2-2) was also reported for other tumor types, such as HCC, breast, lung, and esophageal cancer [7–13]. The gene discussed is IGF2BP2; the disease is esophageal cancer.